Geneva Partners’s GeneDx Holdings WGS Stock Holding History

Geneva Partners’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,965	Closed	-$440K	–	75
2025 Q1	$440K	Buy	+4,965	New	+$431K	0.23%	48

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Geneva Partners's WGS Position: Q2 2025 in Review

Geneva Partners sold out of GeneDx Holdings (WGS) in Q2 2025, closing a stake of 4,965 shares — an estimated $440K sold.

Geneva Partners first reported a position in WGS in Q1 2025 and held it in 1 quarter. The position peaked at $440K in Q1 2025. 231 funds tracked by Wall St. Rank hold WGS as of Q2 2025.

Geneva Partners reported no remaining GeneDx Holdings position as of Q2 2025 after selling out during the quarter.
Geneva Partners sold 4,965 GeneDx Holdings shares in Q2 2025, an estimated $440K.
Geneva Partners first reported a position in GeneDx Holdings in Q1 2025 and held it in 1 quarter.
Geneva Partners's GeneDx Holdings position peaked at $440K in Q1 2025.
231 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2025.

Based on Geneva Partners's 13F filing for Q2 2025, filed 14 Aug 2025.